The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
Jimenez-Ferrer, Itzia, Bäckström, Filip, Dueñas-Rey, Alfredo, Jewett, Michael, Boza-Serrano, Antonio, Luk, Kelvin C., Deierborg, Tomas, Swanberg, MariaЖурнал:
Brain, Behavior, and Immunity
DOI:
10.1016/j.bbi.2020.10.017
Date:
October, 2020
Файл:
PDF, 694 KB
2020
File converter
Більше результатів пошуку
More benefits 
